SyntheticMR AB (publ) (NGM: SYNT)
Health Care · Health Care Technology · SE
Skr—
— today · — 1Y
SyntheticMR AB (publ) (NGM: SYNT) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $111.51M.
trading between 17.30 and 35.20.
Tweenvest scores SyntheticMR AB (publ) across four factors: quality 60/100, growth 67/100. Its strongest factor is growth.
SYNT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $111.51M
- Revenue (TTM)
- $6.53M
- P/E
- —
- EPS
- -0.72
- Dividend yield
- —
- Beta (5Y)
- 0.74
- 52-week high
- Skr35.20
- 52-week low
- Skr17.30
- Avg volume (3M)
- —
- Shares outstanding
- 41.65M
- Employees
- —
- Next earnings
- —
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Veeva Systems Inc.NYSE: VEEV | $40.09B | $246.78 | -0.68% |
| Pro Medicus LimitedASX: PME | $14.25B | AU$190.60 | -1.46% |
| M3, Inc.TSE: 2413 | $7.33B | ¥1,750.00 | +1.77% |
| Sectra AB (publ)OM: SECT B | $5.62B | Skr276.20 | +0.15% |
| Waystar Holding Corp.NasdaqGS: WAY | $4.64B | $24.21 | -4.50% |
| Doximity, Inc.NYSE: DOCS | $4.41B | $24.74 | -2.21% |
| HeartFlow, Inc.NasdaqGS: HTFL | $4.34B | $49.89 | -0.62% |
| Inventurus Knowledge Solutions LimitedNSEI: IKS | $3.30B | Rs1,840.00 | +6.43% |
Figures last refreshed Aug 18, 2026.